RZANY & HUND, Kurfürstendamm 183, 10707 Berlin, Deutschland.
Abteilung für Dermatochirurgie, Klinik für Dermatologie, Venerologie und Allergologie, Ruhr-Universität Bochum, Bochum, Deutschland.
J Dtsch Dermatol Ges. 2018 Jul;16(7):945-952. doi: 10.1111/ddg.13579.
Focal hyperhidrosis can have a considerable impact on social and occupational activities and be associated with significant impairment in quality of life. Primary (idiopathic) hyperhidrosis is neither caused by systemic disorders nor by external factors. It usually occurs in areas characterized by a high density of sweat glands such as the axillae and hands. The diagnosis of focal hyperhidrosis is based on history and clinical findings. Supplementary diagnostic tests include gravimetry (measurement of the amount of sweat) and the iodine starch test (which shows the area of sweating). Treatment options consist of topical agents, botulinum toxin A injections, iontophoresis, treatment with radiofrequency, microwaves, or ultrasound as well as surgical procedures (axillary suction curettage, sympathectomy). Systemic agents such as anticholinergics may also be used. Selection of the most appropriate therapeutic approach depends on the site affected, prior treatment as well as the patient's requests.
局限性多汗症会对社交和职业活动产生重大影响,并导致生活质量显著下降。原发性(特发性)多汗症既不是由系统性疾病引起的,也不是由外部因素引起的。它通常发生在汗腺密度较高的区域,如腋窝和手部。局限性多汗症的诊断基于病史和临床发现。辅助诊断测试包括称重法(测量出汗量)和碘淀粉试验(显示出汗区域)。治疗选择包括局部制剂、肉毒杆菌毒素 A 注射、离子电渗疗法、射频、微波或超声治疗以及手术治疗(腋窝抽吸刮除术、交感神经切除术)。全身性药物,如抗胆碱能药物,也可使用。选择最合适的治疗方法取决于受影响的部位、先前的治疗以及患者的要求。